VANGUARD GROUP INC

Holdings History for Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Symbol: MNPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$19,186,185	293,816	+85,598	+41%	$65.30	Q4 2025
30 Sep 2025	0%	+0%	$17,005,165	208,218	+121,729	+141%	$81.67	Q3 2025
30 Jun 2025	0%	+0%	$3,094,576	86,489	+31,255	+57%	$35.78	Q2 2025
31 Mar 2025	0%	-0%	$2,011,070	55,234	-1,275		$36.41	Q1 2025
31 Dec 2024	0%	+0%	$1,243,198	56,509	+56,509	NEW	$22.00	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.